How are energy investors positioned?
James Michael C, a director at Guided Therapeutics Inc. (OTC:GTHP), made significant purchases of the company's stock, according to a recent SEC filing. The micro-cap company, currently valued at $5.23 million, has seen its stock decline over 55% in the past six months. On March 18, 2025, James acquired a total of 412,945 shares of common stock through two separate transactions.
In the first transaction, James purchased 150,000 shares at a price of $0.10 per share, amounting to $15,000. The second transaction involved the acquisition of 262,945 shares, also at $0.10 per share, for a total of $26,294. The transactions were part of a Securities Purchase Agreement, which included the issuance of warrants to purchase additional shares. According to InvestingPro data, the company's financial health score is rated as WEAK, with short-term obligations exceeding liquid assets.
Following these transactions, James holds a total of 525,717 shares in Guided Therapeutics, reflecting his continued investment in the company. Track insider transactions and access detailed financial analysis with InvestingPro, which offers 8 additional key insights about GTHP's market position and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.